Medicoeconomic assessment of epilepsy surgery in adults with medically intractable partial epilepsy. Three-year outcomes from a multicenter French cohort
PURPOSE: To compare resective surgery and medical therapy in a cost-effectiveness analysis in a multicenter cohort of adult patients with partial intractable epilepsy.
POPULATION AND METHODS: Adult patients with partial, medically intractable, potentially operable epilepsy were eligible and followed every year over five years. Effectiveness was defined as one year without seizure. The long-term costs and effectiveness were extrapolated over the patients' lifetime with a Markov model. Productivity (indirect costs) and quality of life (QOLIE-31, SEALS) were also assessed. Changes before and after surgery were compared between the two groups.
RESULTS: Two hundred and eighty-nine patients were included (119 with surgery, 161 medically treated, six not eligible, three lost to follow-up). One year after surgery, 81% of the patients were seizure-free; at two and three years, this rate was 78%. In the medical group, these rates were 10, 18, and 15%, respectively. The cost of the explorations was euro 8464; including surgery, it was euro 19,700. In the medical group, the average annual direct costs were between 3500 and euro 6000. At two years after surgery, the annual direct cost decreased to euro 2768, at three years, it was euro 1233, predominately antiepileptic drug costs. Surgery became cost-effective between seven and eight years. In the surgical group, all the quality-of-life scores improved at one year after surgery and were stable during the second and third years.
CONCLUSION: Surgical therapy was cost-effective at the middle term even though indirect costs were not considered.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2008 |
|---|---|
| Erschienen: |
2008 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:54 |
|---|---|
| Enthalten in: |
Neuro-Chirurgie - 54(2008), 3 vom: 23. Mai, Seite 484-98 |
| Sprache: |
Französisch |
|---|
| Weiterer Titel: |
Evaluation médicoéconomique de la chirurgie des épilepsies partielles pharmacorésistantes de l'adulte. Résultats à trois ans d'une étude prospective multicentrique française |
|---|
| Beteiligte Personen: |
Picot, M-C [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 08.08.2008 Date Revised 19.05.2008 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.neuchi.2008.03.003 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM179195573 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM179195573 | ||
| 003 | DE-627 | ||
| 005 | 20231223153354.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231223s2008 xx |||||o 00| ||fre c | ||
| 024 | 7 | |a 10.1016/j.neuchi.2008.03.003 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0597.xml |
| 035 | |a (DE-627)NLM179195573 | ||
| 035 | |a (NLM)18440571 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a fre | ||
| 100 | 1 | |a Picot, M-C |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Medicoeconomic assessment of epilepsy surgery in adults with medically intractable partial epilepsy. Three-year outcomes from a multicenter French cohort |
| 246 | 3 | 3 | |a Evaluation médicoéconomique de la chirurgie des épilepsies partielles pharmacorésistantes de l'adulte. Résultats à trois ans d'une étude prospective multicentrique française |
| 264 | 1 | |c 2008 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.08.2008 | ||
| 500 | |a Date Revised 19.05.2008 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a PURPOSE: To compare resective surgery and medical therapy in a cost-effectiveness analysis in a multicenter cohort of adult patients with partial intractable epilepsy | ||
| 520 | |a POPULATION AND METHODS: Adult patients with partial, medically intractable, potentially operable epilepsy were eligible and followed every year over five years. Effectiveness was defined as one year without seizure. The long-term costs and effectiveness were extrapolated over the patients' lifetime with a Markov model. Productivity (indirect costs) and quality of life (QOLIE-31, SEALS) were also assessed. Changes before and after surgery were compared between the two groups | ||
| 520 | |a RESULTS: Two hundred and eighty-nine patients were included (119 with surgery, 161 medically treated, six not eligible, three lost to follow-up). One year after surgery, 81% of the patients were seizure-free; at two and three years, this rate was 78%. In the medical group, these rates were 10, 18, and 15%, respectively. The cost of the explorations was euro 8464; including surgery, it was euro 19,700. In the medical group, the average annual direct costs were between 3500 and euro 6000. At two years after surgery, the annual direct cost decreased to euro 2768, at three years, it was euro 1233, predominately antiepileptic drug costs. Surgery became cost-effective between seven and eight years. In the surgical group, all the quality-of-life scores improved at one year after surgery and were stable during the second and third years | ||
| 520 | |a CONCLUSION: Surgical therapy was cost-effective at the middle term even though indirect costs were not considered | ||
| 650 | 4 | |a English Abstract | |
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Anticonvulsants |2 NLM | |
| 700 | 1 | |a Jaussent, A |e verfasserin |4 aut | |
| 700 | 1 | |a Kahane, P |e verfasserin |4 aut | |
| 700 | 1 | |a Crespel, A |e verfasserin |4 aut | |
| 700 | 1 | |a Gélisse, P |e verfasserin |4 aut | |
| 700 | 1 | |a Hirsch, E |e verfasserin |4 aut | |
| 700 | 1 | |a Derambure, P |e verfasserin |4 aut | |
| 700 | 1 | |a Dupont, S |e verfasserin |4 aut | |
| 700 | 1 | |a Landré, E |e verfasserin |4 aut | |
| 700 | 1 | |a Chassoux, F |e verfasserin |4 aut | |
| 700 | 1 | |a Valton, L |e verfasserin |4 aut | |
| 700 | 1 | |a Vignal, J-P |e verfasserin |4 aut | |
| 700 | 1 | |a Marchal, C |e verfasserin |4 aut | |
| 700 | 1 | |a Rougier, A |e verfasserin |4 aut | |
| 700 | 1 | |a Lamy, C |e verfasserin |4 aut | |
| 700 | 1 | |a Semah, F |e verfasserin |4 aut | |
| 700 | 1 | |a Biraben, A |e verfasserin |4 aut | |
| 700 | 1 | |a Arzimanoglou, A |e verfasserin |4 aut | |
| 700 | 1 | |a Petit, J |e verfasserin |4 aut | |
| 700 | 1 | |a Thomas, P |e verfasserin |4 aut | |
| 700 | 1 | |a Neveu, D |e verfasserin |4 aut | |
| 700 | 1 | |a Ryvlin, P |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Neuro-Chirurgie |d 1955 |g 54(2008), 3 vom: 23. Mai, Seite 484-98 |w (DE-627)NLM000278734 |x 1773-0619 |7 nnns |
| 773 | 1 | 8 | |g volume:54 |g year:2008 |g number:3 |g day:23 |g month:05 |g pages:484-98 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.neuchi.2008.03.003 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 54 |j 2008 |e 3 |b 23 |c 05 |h 484-98 | ||